Late-Onset Paraplegia after Complete Response to Two Cycles of Ipilimumab for Metastatic Melanoma.

MLA

O’Kane, Grainne M., et al. “Late-Onset Paraplegia after Complete Response to Two Cycles of Ipilimumab for Metastatic Melanoma.” Oncology Research & Treatment, vol. 37, no. 12, Dec. 2014, pp. 757–60. EBSCOhost, https://doi.org/10.1159/000368316.

APA

O’Kane, G. M., Lyons, T. G., Colleran, G. C., ahmad, M. W., alken, S., Kavanagh, E. C., Fitzpatrick, D., Murray, B., & Kelly, C. M. (2014). Late-Onset Paraplegia after Complete Response to Two Cycles of Ipilimumab for Metastatic Melanoma. Oncology Research & Treatment, 37(12), 757–760. https://doi.org/10.1159/000368316

Chicago

O’Kane, Grainne M., Tomas G. Lyons, Gabrielle C. Colleran, Marzuki Wan ahmad, Scheryll alken, Eoin C. Kavanagh, David Fitzpatrick, Brian Murray, and Catherine M. Kelly. 2014. “Late-Onset Paraplegia after Complete Response to Two Cycles of Ipilimumab for Metastatic Melanoma.” Oncology Research & Treatment 37 (12): 757–60. doi:10.1159/000368316.